The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

21 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, synthesis, and structure-activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitors.EBI
Bristol-Myers Squibb Pharmaceutical Research Institute
Modeling of binding modes and inhibition mechanism of some natural ligands of farnesyl transferase using molecular docking.EBI
University of Milan
Successful virtual screening of a chemical database for farnesyltransferase inhibitor leads.EBI
Mayo Medical School and Mayo Clinic
Structure-activity relationships of cysteine-lacking pentapeptide derivatives that inhibit ras farnesyltransferase.EBI
Warner-Lambert
Ras farnesyltransferase: a new therapeutic target.EBI
Warner-Lambert
 
Phenolic replacements for cysteine in farnesyl transferase inhibitors based on CVFMEBI
TBA
 
Constrained analogs of KCVFM with improved inhibitory properties against farnesyl transferaseEBI
TBA
 
Stereochemistry of the benzodiazepine based Ras farnesyltransferase inhibitorsEBI
TBA
 
Peptide based P21RAS farnesyl transferase inhibitors: systematic modification of the tetrapeptide CA1A2X motifEBI
TBA
Evaluation of amino acid-based linkers in potent macrocyclic inhibitors of farnesyl-protein transferase.EBI
Merck Research Laboratories
Diaryl ether inhibitors of farnesyl-protein transferase.EBI
Merck Research Laboratories
Discovery of a series of cyclohexylethylamine-containing protein farnesyltransferase inhibitors exhibiting potent cellular activity.EBI
Abbott Laboratories
Solid-phase synthesis of novel inhibitors of farnesyl transferase.EBI
Institute of Cancer Research
Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazine.EBI
Schering-Plough Research Institute
A new class of highly potent farnesyl diphosphate-competitive inhibitors of farnesyltransferase.EBI
Tsukuba Research Institute
C-terminal modifications of histidyl-N-benzylglycinamides to give improved inhibition of Ras farnesyltransferase, cellular activity, and anticancer activity in mice.EBI
Warner-Lambert
Novel benzimidazole phosphonates as potential inhibitors of protein prenylation.EBI
University of Iowa
2-substituted piperazines as constrained amino acids. Application to the synthesis of potent, non carboxylic acid inhibitors of farnesyltransferase.EBI
Merck Research Laboratories
Interrogating the Roles of Post-Translational Modifications of Non-Histone Proteins.EBI
Temple University
Solvent and guest isotope effects on complexation thermodynamics of alpha-, beta-, and 6-amino-6-deoxy-beta-cyclodextrins.BDB
Japan Science and Technology Agency
 
Thermodynamic Origin of Molecular Selective Binding of Bile Salts by Aminated β-CyclodextrinsBDB
Nankai University